64Cu

You have access
PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor
Haiming Luo, Hao Hong, Michael R. Slater, Stephen A. Graves, Sixiang Shi, Yunan Yang, Robert J. Nickles, Frank Fan and Weibo Cai

Journal of Nuclear Medicine May 1, 2015, 56 (5) 758-763; DOI: https://doi.org/10.2967/jnumed.115.154690
You have access
Detection of Increased ⁶⁴Cu Uptake by Human Copper Transporter 1 Gene Overexpression Using PET with ⁶⁴CuCl₂ in Human Breast Cancer Xenograft Model
Kwang Il Kim, Su Jin Jang, Ju Hui Park, Yong Jin Lee, Tae Sup Lee, Kwang Sun Woo, Hyun Park, Jae Gol Choe, Gwang Il An and Joo Hyun Kang

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1692-1698; DOI: https://doi.org/10.2967/jnumed.114.141127
You have access
N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of ⁶⁸Ga- and ⁶⁴Cu-Labeled Peptides for PET Imaging
Eleni Gourni, Rosalba Mansi, Mazen Jamous, Beatrice Waser, Christiane Smerling, Antje Burian, Franz Buchegger, Jean Claude Reubi and Helmut R. Maecke

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1719-1725; DOI: https://doi.org/10.2967/jnumed.114.141242
You have access
A Tyrosine Kinase Inhibitor–Based High-Affinity PET Radiopharmaceutical Targets Vascular Endothelial Growth Factor Receptor
Feng Li, Sheng Jiang, Youli Zu, Daniel Y. Lee and Zheng Li

Journal of Nuclear Medicine September 1, 2014, 55 (9) 1525-1531; DOI: https://doi.org/10.2967/jnumed.114.138925
You have access
Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes
Francesco Blasi, Bruno L. Oliveira, Tyson A. Rietz, Nicholas J. Rotile, Helen Day, Richard J. Looby, Ilknur Ay and Peter Caravan

Journal of Nuclear Medicine July 1, 2014, 55 (7) 1157-1163; DOI: https://doi.org/10.2967/jnumed.113.136275
You have access
⁶⁴Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
Kenji Tamura, Hiroaki Kurihara, Kan Yonemori, Hitoshi Tsuda, Junko Suzuki, Yuzuru Kono, Natsuki Honda, Makoto Kodaira, Harukaze Yamamoto, Mayu Yunokawa, Chikako Shimizu, Koki Hasegawa, Yousuke Kanayama, Satoshi Nozaki, Takayuki Kinoshita, Yasuhiro Wada, Shusaku Tazawa, Kazuhiro Takahashi, Yasuyoshi Watanabe and Yasuhiro Fujiwara

Journal of Nuclear Medicine November 1, 2013, 54 (11) 1869-1875; DOI: https://doi.org/10.2967/jnumed.112.118612
You have access
The Role of p53 in Combination Radioimmunotherapy with ⁶⁴Cu-DOTA-Cetuximab and Cisplatin in a Mouse Model of Colorectal Cancer
Yunjun Guo, Jesse J. Parry, Richard Laforest, Buck E. Rogers and Carolyn J. Anderson

Journal of Nuclear Medicine September 1, 2013, 54 (9) 1621-1629; DOI: https://doi.org/10.2967/jnumed.112.118539
You have access
PET Imaging of Colorectal and Breast Cancer by Targeting EphB4 Receptor with ⁶⁴Cu-Labeled hAb47 and hAb131 Antibodies
Shuanglong Liu, Dan Li, Ryan Park, Ren Liu, Zanxian Xia, Jiacong Guo, Valery Krasnoperov, Parkash S. Gill, Zibo Li, Hong Shan and Peter S. Conti

Journal of Nuclear Medicine July 1, 2013, 54 (7) 1094-1100; DOI: https://doi.org/10.2967/jnumed.112.116822
You have access
Immuno-PET of Tissue Factor in Pancreatic Cancer
Hao Hong, Yin Zhang, Tapas R. Nayak, Jonathan W. Engle, Hing C. Wong, Bai Liu, Todd E. Barnhart and Weibo Cai

Journal of Nuclear Medicine November 1, 2012, 53 (11) 1748-1754; DOI: https://doi.org/10.2967/jnumed.112.105460
You have access
⁶⁴Cu-p-NH₂-Bn-DOTA-hu14.18K322A, a PET Radiotracer Targeting Neuroblastoma and Melanoma
Amy L. Vāvere, Elizabeth R. Butch, Jason L.J. Dearling, Alan B. Packard, Fariba Navid, Barry L. Shulkin, Raymond C. Barfield and Scott E. Snyder

Journal of Nuclear Medicine November 1, 2012, 53 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.112.104208

Main menu

User menu

Search

64Cu

Pages